These procedures change the stomach and small intestine to limit food intake, improve digestion, and boost metabolism
Your First Appointment Expect a thorough health history review, discussion of goals and expectations, and a clear explanation of the procedure
[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment
doi: 10.1111/jdi.12445 12 TakedaYFujitaYYanagimachiTMaruyamaNBesshoRSakagamiHet al
Start your intake How Tirzepatide Causes Injection Site Itching Tirzepatide is a dual GLP-1 and GIP receptor agonist that activates cellular pathways involved in appetite regulation and metabolism
These observational studies cannot prove causation, but the dose response patterns support prudent dose minimization and monitoring